**Digoxin-Model** Digoxin-Model, Whole-body PBPK model of Digoxin. ([https://github.com/Open-Systems-Pharmacology/Digoxin-Model](https://github.com/Open-Systems-Pharmacology/Digoxin-Model))

**Edginton 2006** Edginton AN, Schmitt W, Willmann S. Development and evaluation of a generic physiologically based pharmacokinetic model for children. Clin Pharmacokinet. 2006;45(10):1013-34.

**Maharaj 2013** Maharaj AR, Barrett JS, Edginton AN. A workflow example of PBPK modeling to support pediatric research and development: case study with lorazepam. The AAPS journal. 2013;15(2): 455-464.

**Meistelman 1987** Meistelman C, Saint-Maurice C, Lepaul M, Levron JC, Loose JP, Mac Gee K. A comparison of alfentanil pharmacokinetics in children and adults. Anesthesiology. 1987 Jan;66(1):13-6.

**Nyberg 1980 **Nyberg L, Wettrell G. Pharmacokinetics and dosage of digoxin in neonates and infants. Eur J Clin Pharmacol. 1980 Jul;18(1):69-74.

**Ontogeny Database** OSPSuite.Documentation/PK-Sim Ontogeny Database Version 7.3.pdf ([https://github.com/Open-Systems-Pharmacology/OSPSuite.Documentation/blob/38cf71b384cfc25cfa0ce4d2f3addfd32757e13b/PK-Sim%20Ontogeny%20Database%20Version%207.3.pdf](https://github.com/Open-Systems-Pharmacology/OSPSuite.Documentation/blob/38cf71b384cfc25cfa0ce4d2f3addfd32757e13b/PK-Sim%20Ontogeny%20Database%20Version%207.3.pdf))

**Rane 1976** Rane A, Wilson JT. Clinical pharmacokinetics in infants and children. Clin Pharmacokinet. 1976;1(1):2-24.

**Ratnapalan 2003** Ratnapalan S, Griffiths K, Costei AM, Benson L, Koren G. Digoxin-carvedilol interactions in children. J Pediatr. 2003 May;142(5):572-4.